Moderate-intensity statin plus ezetimibe combination therapy versus high-intensity statin monotherapy according to baseline LDL-C levels: a prespecified subgroup analysis of RACING Trial

被引：0
|
作者：
Lee, B. [1 ]
Hong, S. [1 ]
Kim, J. [1 ,7 ]
Rha, S. [2 ]
Heo, J. [3 ]
Hur, S. [4 ]
Choi, H. [5 ]
Kim, K. [6 ]
Kim, J. [1 ,7 ]
Kim, H. [8 ]
Kim, W. [9 ]
Choi, Y. [10 ]
Kim, B. [1 ]
Hong, M. [1 ]
Jang, Y. [11 ]
机构：
[1] Yonsei Univ, Seoul, South Korea
[2] Korea Univ, Guro Hosp, Seoul, South Korea
[3] Kosin Univ, Sch Med, Busan, South Korea
[4] Keimyung Univ, Dongsan Med Ctr, Daegu, South Korea
[5] Hallym Univ, Chunchon, South Korea
[6] Ewha Womans Univ, Seoul, South Korea
[7] Chonnam Natl Univ Hosp, Gwangju, South Korea
[8] Chosun Univ Hosp, Gwangju, South Korea
[9] Yeungnam Univ Hosp, Daegu, South Korea
[10] Eulji Univ Hosp, Deajeon, South Korea
[11] Cha Bundang, Med Ctr, Seongnam, South Korea
来源：
EUROPEAN HEART JOURNAL | 2023年 / 44卷
关键词：
D O I：
暂无
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
引用
收藏
页数：1
相关论文
共 47 条
  • [31] RESEARCH (Recognized effect of Statin and ezetimibe therapy for achieving LDL-C Goal), a randomized, doctor-oriented, multicenter trial to compare the effects of higher-dose statin versus ezetimibe-plus-statin on the serum LDL-C concentration of Japanese type-2 diabetes patients design and rationale
    Inazawa, Takeshi
    Sakamoto, Kentaro
    Kohro, Takahide
    Iijima, Raisuke
    Kitazawa, Toru
    Hirano, Tsutomu
    Kawamura, Mitsunobu
    Tagami, Motoki
    Tanaka, Akira
    Mori, Yasumichi
    Yamazaki, Tsutomu
    Shiba, Teruo
    [J]. LIPIDS IN HEALTH AND DISEASE, 2013, 12
  • [32] RESEARCH (Recognized effect of Statin and ezetimibe therapy for achieving LDL-C Goal), a randomized, doctor-oriented, multicenter trial to compare the effects of higher-dose statin versus ezetimibe-plus-statin on the serum LDL-C concentration of Japanese type-2 diabetes patients design and rationale
    Takeshi Inazawa
    Kentaro Sakamoto
    Takahide Kohro
    Raisuke Iijima
    Toru Kitazawa
    Tsutomu Hirano
    Mitsunobu Kawamura
    Motoki Tagami
    Akira Tanaka
    Yasumichi Mori
    Tsutomu Yamazaki
    Teruo Shiba
    [J]. Lipids in Health and Disease, 12
  • [33] Moderate-intensity versus high-intensity statin therapy in Korean patients with angina undergoing percutaneous coronary intervention with drug-eluting stents: A propensity-score matching analysis
    Park, Mahn-Won
    Park, Gyung-Min
    Han, Seungbong
    Yang, Yujin
    Kim, Yong-Giun
    Roh, Jae-Hyung
    Park, Hyun Woo
    Suh, Jon
    Cho, Young-Rak
    Won, Ki-Bum
    Ann, Soe Hee
    Kim, Shin-Jae
    Kim, Dae-Won
    Her, Sung Ho
    Lee, Sang-Gon
    [J]. PLOS ONE, 2018, 13 (12):
  • [34] Comparative Analysis of High-Intensity versus Low-to-Moderate Intensity Statin Therapy in Patients Undergoing Rotational Atherectomy for Calcified Coronary Artery Disease
    Choi, Sang-Suk
    Jung, Jin
    Her, Sung-Ho
    Kim, Kyunyeon
    Kim, Youngmin
    Lee, Kyusup
    Yoo, Ki-Dong
    Moon, Keon-Woong
    Moon, Donggyu
    Lee, Su-Nam
    Jang, Won-Young
    Choi, Ik-Jun
    Lee, Jae-Hwan
    Lee, Jang-Hoon
    Lee, Sang-Rok
    Lee, Seung-Whan
    Yun, Kyeong-Ho
    Lee, Hyun-Jong
    Diez-Juan, Antonio
    [J]. LIFE-BASEL, 2023, 13 (11):
  • [35] EFFICACY OF SWITCHING FROM STATIN MONOTHERAPY TO EZETIMIBE/SIMVASTATIN 10/20 mg VERSUS ROSUVASTATIN 10 mg IN HIGH-RISK PATIENTS ANALYZED BY BASELINE LDL-C
    Brudi, P.
    Averna, M.
    Farnier, M.
    Missault, L.
    Vaverkova, H.
    Viigimaa, L. M.
    Dong, Q.
    Shah, A.
    Taggart, W.
    Johnson-Levonas, A.
    [J]. ATHEROSCLEROSIS SUPPLEMENTS, 2010, 11 (02) : 189 - 189
  • [36] Impact of Baseline Lipoprotein and C-Reactive Protein Levels on Coronary Atheroma Regression. Following High-Intensity Statin Therapy
    Puri, Rishi
    Sen, Steven E. Nis.
    Shao, Mingyuan
    Uno, Kiyoko
    Kataoka, Yu
    Kapadia, Samir R.
    Tuzcu, E. Murat
    Nicholls, Stephen J.
    [J]. AMERICAN JOURNAL OF CARDIOLOGY, 2014, 114 (10): : 1465 - 1472
  • [37] Moderate-Intensity Rosuvastatin Plus Ezetimibe Versus High-Intensity Rosuvastatin for Target Low-Density Lipoprotein Cholesterol Goal Achievement in Patients With Recent Ischemic Stroke: A Randomized Controlled Trial
    Hong, Keun-Sik
    Bang, Oh Young
    Park, Jong -Ho
    Jung, Jin-Man
    Lee, Sang -Hun
    Song, Tae-Jin
    Nam, Hyo Suk
    Park, Hee-Kwon
    Jung, Keun-Hwa
    Heo, Sung Hyuk
    Koo, Jaseong
    Yu, Kyung-Ho
    Park, Kwang-Yeol
    Kim, Chi Kyung
    Park, Hong-Kyun
    Lee, Jiyoon
    Lee, Juneyoung
    Seo, Woo-Keun
    [J]. JOURNAL OF STROKE, 2023, 25 (02) : 242 - +
  • [38] EFFICACY AND SAFETY OF BEMPEDOIC ACID plus EZETIMIBE FIXED-DOSE COMBINATION IN PATIENTS AT HIGH CVD RISK AND WITH ELEVATED LDL-C RECEIVING MAXIMALLY TOLERATED STATIN THERAPY
    Ballantyne, C.
    Laufs, U.
    Ray, K. K.
    Leiter, L. A.
    Bays, H. E.
    Goldberg, A. C.
    Stroes, E. S. G.
    MacDougall, D.
    Zhao, X.
    Catapano, A. L.
    [J]. ATHEROSCLEROSIS, 2019, 287 : E7 - E8
  • [39] Lack of low-density lipoprotein cholesterol (LDL-C) goal attainment among high-risk patients using high or moderate intensity statin therapy in Germany
    Fox, K. M.
    Kostev, K.
    Von Vultee, C.
    Hatz, M.
    Tai, M. -H.
    Qian, Y.
    [J]. EUROPEAN HEART JOURNAL, 2017, 38 : 463 - 463
  • [40] Moderate versus high-intensity statin therapy in east asian patients with angina undergoing PCI with DES: a propensity-score matching analysis
    Park, M. -W.
    Her, S. H.
    Cho, J. S.
    Park, H. W.
    Kim, D. W.
    Kim, T. S.
    Park, K. M.
    Chang, K. Y.
    [J]. EUROPEAN HEART JOURNAL, 2018, 39 : 1164 - 1164
12345